Guest Speakers:

Ameet Upadhyaya, MD

Department of Diagnostic and Neuroradiology, University of Pittsburgh

Course Director, President of The Pittsburgh Roentgen Society

Anish Ghodadra, MD

Assistant Professor, Interventional Radiology, Medical Director, 3D Printing, University of

Pittsburgh

Program Overview:

Participants will review interesting cases in Interventional Radiology and be familiarized with

challenging conditions encountered in an interventional radiology setting.

Learning Objectives:

Participants will be able to discuss common dilemmas and potential problem solving

techniques via case based discussion and literature review.

Charles White, MD

Professor of Radiology and Internal Medicine, University of Maryland

Vice Chair of Clinical Affairs and Director of Thoracic Imaging, University of Maryland

Program Overview:

Participants will be familiarized with old and new insights for recognition of pulmonary

embolism imaging on CT.

Learning Objectives:

Participants will understand and be able to discuss common applications

No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.